The MYC Oncogene as a Cancer Drug Target

E-ISSN： 1873-5576|3|3|163-175

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.3, Iss.3, 2003-06, pp. : 163-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

MDM2 Oncogene as a Novel Target for Human Cancer Therapy

Current Pharmaceutical Design, Vol. 6, Iss. 4, 2000-03 ,pp. : 393-416

Bentham Science Publishers

Access to resources Recommend Favorite

The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth

By Pelengaris Stella Khan Mike

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 5, 2003-10 ,pp. : 623-642

Informa Healthcare

Access to resources Recommend Favorite

Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol. 4, Iss. 3, 2004-09 ,pp. : 253-256

Bentham Science Publishers

Access to resources Recommend Favorite

The MYCN Oncogene as a Specific and Selective Drug Target for Peripheral and Central Nervous System Tumors

Current Cancer Drug Targets, Vol. 5, Iss. 4, 2005-06 ,pp. : 273-283

Bentham Science Publishers

Access to resources Recommend Favorite

gp130: a promising drug target for cancer therapy

By Xu Shili Neamati Nouri

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 11, 2013-11 ,pp. : 1303-1328

Informa Healthcare

Access to resources Recommend Favorite